| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004236 | American Journal of Ophthalmology | 2009 | 9 Pages |
Abstract
In patients with persistent ME resulting from uveitis or Irvine-Gass syndrome, 700-μg dexamethasone DDS was well tolerated and produced statistically significant improvements in visual acuity and fluorescein leakage.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
George A. Williams, Julia A. Haller, Baruch D. Kuppermann, Mark S. Blumenkranz, David V. Weinberg, Connie Chou, Scott M. Whitcup, The Dexamethasone DDS Phase II Study Group The Dexamethasone DDS Phase II Study Group,